CHKA and hepatocellular carcinoma: Based on these results, we can conclude that CKI can improve the therapeutic efficacy in patients with advanced HCC undergoing TACE therapy, especially regimens with chemotherapeutic drugs with high levels of adriamycins (EPI and THP) and HCPT.